Medical Care
Global Chronic Hepatitis B Treatment Market Research Report 2025
- May 12, 25
- ID: 236207
- Pages: 74
- Figures: 72
- Views: 1
The global market for Chronic Hepatitis B Treatment was valued at US$ 4760 million in the year 2024 and is projected to reach a revised size of US$ 6158 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medicines — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine — can help fight the virus and slow its ability to damage your liver. These drugs are taken by mouth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Treatment.
The Chronic Hepatitis B Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Hepatitis B Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Hepatitis B Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
ViiV Healthcare
Bristol-Myers Squibb
Gilead Sciences
Accord Healthcare
Teva Pharmaceuticals
Apotex Corp
CTTQ
Arbutus Biopharma
Lupin Pharmaceuticals
Segment by Type
Interferon
Antiviral Drugs
Segment by Application
Hospitals
Homecare
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Hepatitis B Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medicines — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine — can help fight the virus and slow its ability to damage your liver. These drugs are taken by mouth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Treatment.
The Chronic Hepatitis B Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Hepatitis B Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Hepatitis B Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
ViiV Healthcare
Bristol-Myers Squibb
Gilead Sciences
Accord Healthcare
Teva Pharmaceuticals
Apotex Corp
CTTQ
Arbutus Biopharma
Lupin Pharmaceuticals
Segment by Type
Interferon
Antiviral Drugs
Segment by Application
Hospitals
Homecare
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Hepatitis B Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Hepatitis B Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interferon
1.2.3 Antiviral Drugs
1.3 Market by Application
1.3.1 Global Chronic Hepatitis B Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Hepatitis B Treatment Market Perspective (2020-2031)
2.2 Global Chronic Hepatitis B Treatment Growth Trends by Region
2.2.1 Global Chronic Hepatitis B Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Hepatitis B Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Hepatitis B Treatment Market Dynamics
2.3.1 Chronic Hepatitis B Treatment Industry Trends
2.3.2 Chronic Hepatitis B Treatment Market Drivers
2.3.3 Chronic Hepatitis B Treatment Market Challenges
2.3.4 Chronic Hepatitis B Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Hepatitis B Treatment Players by Revenue
3.1.1 Global Top Chronic Hepatitis B Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Hepatitis B Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Hepatitis B Treatment Revenue
3.4 Global Chronic Hepatitis B Treatment Market Concentration Ratio
3.4.1 Global Chronic Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Hepatitis B Treatment Revenue in 2024
3.5 Global Key Players of Chronic Hepatitis B Treatment Head office and Area Served
3.6 Global Key Players of Chronic Hepatitis B Treatment, Product and Application
3.7 Global Key Players of Chronic Hepatitis B Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Hepatitis B Treatment Breakdown Data by Type
4.1 Global Chronic Hepatitis B Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Hepatitis B Treatment Breakdown Data by Application
5.1 Global Chronic Hepatitis B Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Hepatitis B Treatment Market Size (2020-2031)
6.2 North America Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Hepatitis B Treatment Market Size (2020-2031)
7.2 Europe Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Hepatitis B Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Hepatitis B Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Hepatitis B Treatment Market Size (2020-2031)
9.2 Latin America Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Hepatitis B Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Chronic Hepatitis B Treatment Introduction
11.1.4 Novartis Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Details
11.2.2 ViiV Healthcare Business Overview
11.2.3 ViiV Healthcare Chronic Hepatitis B Treatment Introduction
11.2.4 ViiV Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.2.5 ViiV Healthcare Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Chronic Hepatitis B Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Chronic Hepatitis B Treatment Introduction
11.4.4 Gilead Sciences Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Chronic Hepatitis B Treatment Introduction
11.5.4 Accord Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.5.5 Accord Healthcare Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Chronic Hepatitis B Treatment Introduction
11.6.4 Teva Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Apotex Corp
11.7.1 Apotex Corp Company Details
11.7.2 Apotex Corp Business Overview
11.7.3 Apotex Corp Chronic Hepatitis B Treatment Introduction
11.7.4 Apotex Corp Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.7.5 Apotex Corp Recent Development
11.8 CTTQ
11.8.1 CTTQ Company Details
11.8.2 CTTQ Business Overview
11.8.3 CTTQ Chronic Hepatitis B Treatment Introduction
11.8.4 CTTQ Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.8.5 CTTQ Recent Development
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Details
11.9.2 Arbutus Biopharma Business Overview
11.9.3 Arbutus Biopharma Chronic Hepatitis B Treatment Introduction
11.9.4 Arbutus Biopharma Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.9.5 Arbutus Biopharma Recent Development
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Details
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Chronic Hepatitis B Treatment Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.10.5 Lupin Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Hepatitis B Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interferon
1.2.3 Antiviral Drugs
1.3 Market by Application
1.3.1 Global Chronic Hepatitis B Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Hepatitis B Treatment Market Perspective (2020-2031)
2.2 Global Chronic Hepatitis B Treatment Growth Trends by Region
2.2.1 Global Chronic Hepatitis B Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Hepatitis B Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chronic Hepatitis B Treatment Market Dynamics
2.3.1 Chronic Hepatitis B Treatment Industry Trends
2.3.2 Chronic Hepatitis B Treatment Market Drivers
2.3.3 Chronic Hepatitis B Treatment Market Challenges
2.3.4 Chronic Hepatitis B Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Hepatitis B Treatment Players by Revenue
3.1.1 Global Top Chronic Hepatitis B Treatment Players by Revenue (2020-2025)
3.1.2 Global Chronic Hepatitis B Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Hepatitis B Treatment Revenue
3.4 Global Chronic Hepatitis B Treatment Market Concentration Ratio
3.4.1 Global Chronic Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Hepatitis B Treatment Revenue in 2024
3.5 Global Key Players of Chronic Hepatitis B Treatment Head office and Area Served
3.6 Global Key Players of Chronic Hepatitis B Treatment, Product and Application
3.7 Global Key Players of Chronic Hepatitis B Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Hepatitis B Treatment Breakdown Data by Type
4.1 Global Chronic Hepatitis B Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031)
5 Chronic Hepatitis B Treatment Breakdown Data by Application
5.1 Global Chronic Hepatitis B Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Hepatitis B Treatment Market Size (2020-2031)
6.2 North America Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
6.4 North America Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Hepatitis B Treatment Market Size (2020-2031)
7.2 Europe Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
7.4 Europe Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Hepatitis B Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chronic Hepatitis B Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Hepatitis B Treatment Market Size (2020-2031)
9.2 Latin America Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
9.4 Latin America Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Hepatitis B Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Chronic Hepatitis B Treatment Introduction
11.1.4 Novartis Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Details
11.2.2 ViiV Healthcare Business Overview
11.2.3 ViiV Healthcare Chronic Hepatitis B Treatment Introduction
11.2.4 ViiV Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.2.5 ViiV Healthcare Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Chronic Hepatitis B Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Chronic Hepatitis B Treatment Introduction
11.4.4 Gilead Sciences Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Chronic Hepatitis B Treatment Introduction
11.5.4 Accord Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.5.5 Accord Healthcare Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Chronic Hepatitis B Treatment Introduction
11.6.4 Teva Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Apotex Corp
11.7.1 Apotex Corp Company Details
11.7.2 Apotex Corp Business Overview
11.7.3 Apotex Corp Chronic Hepatitis B Treatment Introduction
11.7.4 Apotex Corp Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.7.5 Apotex Corp Recent Development
11.8 CTTQ
11.8.1 CTTQ Company Details
11.8.2 CTTQ Business Overview
11.8.3 CTTQ Chronic Hepatitis B Treatment Introduction
11.8.4 CTTQ Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.8.5 CTTQ Recent Development
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Details
11.9.2 Arbutus Biopharma Business Overview
11.9.3 Arbutus Biopharma Chronic Hepatitis B Treatment Introduction
11.9.4 Arbutus Biopharma Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.9.5 Arbutus Biopharma Recent Development
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Details
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Chronic Hepatitis B Treatment Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025)
11.10.5 Lupin Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Interferon
Table 3. Key Players of Antiviral Drugs
Table 4. Global Chronic Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Chronic Hepatitis B Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Chronic Hepatitis B Treatment Market Share by Region (2020-2025)
Table 8. Global Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Chronic Hepatitis B Treatment Market Share by Region (2026-2031)
Table 10. Chronic Hepatitis B Treatment Market Trends
Table 11. Chronic Hepatitis B Treatment Market Drivers
Table 12. Chronic Hepatitis B Treatment Market Challenges
Table 13. Chronic Hepatitis B Treatment Market Restraints
Table 14. Global Chronic Hepatitis B Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Chronic Hepatitis B Treatment Market Share by Players (2020-2025)
Table 16. Global Top Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment as of 2024)
Table 17. Ranking of Global Top Chronic Hepatitis B Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Chronic Hepatitis B Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Chronic Hepatitis B Treatment, Headquarters and Area Served
Table 20. Global Key Players of Chronic Hepatitis B Treatment, Product and Application
Table 21. Global Key Players of Chronic Hepatitis B Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Hepatitis B Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Chronic Hepatitis B Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Chronic Hepatitis B Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Chronic Hepatitis B Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Chronic Hepatitis B Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Chronic Hepatitis B Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Chronic Hepatitis B Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Chronic Hepatitis B Treatment Product
Table 49. Novartis Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. ViiV Healthcare Company Details
Table 52. ViiV Healthcare Business Overview
Table 53. ViiV Healthcare Chronic Hepatitis B Treatment Product
Table 54. ViiV Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 55. ViiV Healthcare Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Chronic Hepatitis B Treatment Product
Table 59. Bristol-Myers Squibb Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Chronic Hepatitis B Treatment Product
Table 64. Gilead Sciences Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Accord Healthcare Company Details
Table 67. Accord Healthcare Business Overview
Table 68. Accord Healthcare Chronic Hepatitis B Treatment Product
Table 69. Accord Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 70. Accord Healthcare Recent Development
Table 71. Teva Pharmaceuticals Company Details
Table 72. Teva Pharmaceuticals Business Overview
Table 73. Teva Pharmaceuticals Chronic Hepatitis B Treatment Product
Table 74. Teva Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 75. Teva Pharmaceuticals Recent Development
Table 76. Apotex Corp Company Details
Table 77. Apotex Corp Business Overview
Table 78. Apotex Corp Chronic Hepatitis B Treatment Product
Table 79. Apotex Corp Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 80. Apotex Corp Recent Development
Table 81. CTTQ Company Details
Table 82. CTTQ Business Overview
Table 83. CTTQ Chronic Hepatitis B Treatment Product
Table 84. CTTQ Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 85. CTTQ Recent Development
Table 86. Arbutus Biopharma Company Details
Table 87. Arbutus Biopharma Business Overview
Table 88. Arbutus Biopharma Chronic Hepatitis B Treatment Product
Table 89. Arbutus Biopharma Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 90. Arbutus Biopharma Recent Development
Table 91. Lupin Pharmaceuticals Company Details
Table 92. Lupin Pharmaceuticals Business Overview
Table 93. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Product
Table 94. Lupin Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 95. Lupin Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Chronic Hepatitis B Treatment Picture
Figure 2. Global Chronic Hepatitis B Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Hepatitis B Treatment Market Share by Type: 2024 VS 2031
Figure 4. Interferon Features
Figure 5. Antiviral Drugs Features
Figure 6. Global Chronic Hepatitis B Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Chronic Hepatitis B Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Homecare Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Chronic Hepatitis B Treatment Report Years Considered
Figure 13. Global Chronic Hepatitis B Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Chronic Hepatitis B Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Chronic Hepatitis B Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Chronic Hepatitis B Treatment Market Share by Players in 2024
Figure 17. Global Top Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Chronic Hepatitis B Treatment Revenue in 2024
Figure 19. North America Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 21. United States Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 25. Germany Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Chronic Hepatitis B Treatment Market Share by Region (2020-2031)
Figure 33. China Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 49. ViiV Healthcare Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 51. Gilead Sciences Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 52. Accord Healthcare Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 54. Apotex Corp Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 55. CTTQ Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 56. Arbutus Biopharma Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Chronic Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Interferon
Table 3. Key Players of Antiviral Drugs
Table 4. Global Chronic Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Chronic Hepatitis B Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Chronic Hepatitis B Treatment Market Share by Region (2020-2025)
Table 8. Global Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Chronic Hepatitis B Treatment Market Share by Region (2026-2031)
Table 10. Chronic Hepatitis B Treatment Market Trends
Table 11. Chronic Hepatitis B Treatment Market Drivers
Table 12. Chronic Hepatitis B Treatment Market Challenges
Table 13. Chronic Hepatitis B Treatment Market Restraints
Table 14. Global Chronic Hepatitis B Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Chronic Hepatitis B Treatment Market Share by Players (2020-2025)
Table 16. Global Top Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment as of 2024)
Table 17. Ranking of Global Top Chronic Hepatitis B Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Chronic Hepatitis B Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Chronic Hepatitis B Treatment, Headquarters and Area Served
Table 20. Global Key Players of Chronic Hepatitis B Treatment, Product and Application
Table 21. Global Key Players of Chronic Hepatitis B Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Hepatitis B Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Chronic Hepatitis B Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Chronic Hepatitis B Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Chronic Hepatitis B Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Chronic Hepatitis B Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Chronic Hepatitis B Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Chronic Hepatitis B Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Chronic Hepatitis B Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Chronic Hepatitis B Treatment Product
Table 49. Novartis Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. ViiV Healthcare Company Details
Table 52. ViiV Healthcare Business Overview
Table 53. ViiV Healthcare Chronic Hepatitis B Treatment Product
Table 54. ViiV Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 55. ViiV Healthcare Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Chronic Hepatitis B Treatment Product
Table 59. Bristol-Myers Squibb Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Chronic Hepatitis B Treatment Product
Table 64. Gilead Sciences Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Accord Healthcare Company Details
Table 67. Accord Healthcare Business Overview
Table 68. Accord Healthcare Chronic Hepatitis B Treatment Product
Table 69. Accord Healthcare Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 70. Accord Healthcare Recent Development
Table 71. Teva Pharmaceuticals Company Details
Table 72. Teva Pharmaceuticals Business Overview
Table 73. Teva Pharmaceuticals Chronic Hepatitis B Treatment Product
Table 74. Teva Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 75. Teva Pharmaceuticals Recent Development
Table 76. Apotex Corp Company Details
Table 77. Apotex Corp Business Overview
Table 78. Apotex Corp Chronic Hepatitis B Treatment Product
Table 79. Apotex Corp Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 80. Apotex Corp Recent Development
Table 81. CTTQ Company Details
Table 82. CTTQ Business Overview
Table 83. CTTQ Chronic Hepatitis B Treatment Product
Table 84. CTTQ Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 85. CTTQ Recent Development
Table 86. Arbutus Biopharma Company Details
Table 87. Arbutus Biopharma Business Overview
Table 88. Arbutus Biopharma Chronic Hepatitis B Treatment Product
Table 89. Arbutus Biopharma Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 90. Arbutus Biopharma Recent Development
Table 91. Lupin Pharmaceuticals Company Details
Table 92. Lupin Pharmaceuticals Business Overview
Table 93. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Product
Table 94. Lupin Pharmaceuticals Revenue in Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)
Table 95. Lupin Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Chronic Hepatitis B Treatment Picture
Figure 2. Global Chronic Hepatitis B Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Hepatitis B Treatment Market Share by Type: 2024 VS 2031
Figure 4. Interferon Features
Figure 5. Antiviral Drugs Features
Figure 6. Global Chronic Hepatitis B Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Chronic Hepatitis B Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Homecare Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Chronic Hepatitis B Treatment Report Years Considered
Figure 13. Global Chronic Hepatitis B Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Chronic Hepatitis B Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Chronic Hepatitis B Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Chronic Hepatitis B Treatment Market Share by Players in 2024
Figure 17. Global Top Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Chronic Hepatitis B Treatment Revenue in 2024
Figure 19. North America Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 21. United States Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 25. Germany Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Chronic Hepatitis B Treatment Market Share by Region (2020-2031)
Figure 33. China Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Chronic Hepatitis B Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 49. ViiV Healthcare Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 51. Gilead Sciences Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 52. Accord Healthcare Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 54. Apotex Corp Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 55. CTTQ Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 56. Arbutus Biopharma Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Chronic Hepatitis B Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232